US2009123566A1PendingUtilityA1

Use of a phosphate adsorbent to combat vascular diseases

56
Assignee: SEIDEL DIETRICHPriority: Jun 13, 2001Filed: Jan 12, 2009Published: May 14, 2009
Est. expiryJun 13, 2021(expired)· nominal 20-yr term from priority
Inventors:Dietrich SeidelKarl-Siegfried Boos
A61P 9/00A61P 9/10A61P 19/00A61P 19/08A61K 33/26
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and preventing atherosclerotic vascular diseases or/and disturbances of bone metabolism.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled) 
   
   
       14 . A method of treating a patient suffering from atherosclerotic vascular disease and/or disturbances of bone metabolism, comprising orally administering to said patient an adsorption material modified with an iron (III) metal oxide hydroxide in an amount sufficient to reduce the calcium phosphate product in blood from said patient. 
   
   
       15 . The method of  claim 14 , wherein said adsorption material is an insoluble adsorption material. 
   
   
       16 . The method of  claim 15 , wherein said insoluble adsorption material is a carbohydrate. 
   
   
       17 . The method of  claim 16 , wherein said carbohydrate is starch. 
   
   
       18 . The method of  claim 17 , wherein said patient is a dialysis patient. 
   
   
       19 . The method of  claim 17 , wherein said patient is a predialysis patient. 
   
   
       20 . A method of treating a patient suffering from atherosclerotic vascular disease and/or disturbances of bone metabolism, comprising:
 a) selecting a patient for treatment on the basis of suffering from atherosclerotic vascular disease and/or disturbances of bone metabolism; and   b) orally administering to said patient an adsorption material modified with an iron (III) metal oxide hydroxide in an amount sufficient to reduce the calcium phosphate product in blood from said patient.   
   
   
       21 . The method of  claim 20 , wherein said adsorption material is an insoluble adsorption material. 
   
   
       22 . The method of  claim 21 , wherein said insoluble adsorption material is a carbohydrate. 
   
   
       23 . The method of  claim 22 , wherein said carbohydrate is starch. 
   
   
       24 . The method of  claim 23 , wherein said patient is a dialysis patient. 
   
   
       25 . The method of  claim 23 , wherein said patient is a predialysis patient.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.